⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LEXX News
Lexaria Bioscience Corp. Common Stock
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
accessnewswire.com
LEXX
LLY
Lexaria to Begin New Human Clinical Study in GLP-1
accessnewswire.com
LEXX
Lexaria's Robust Patent Portfolio Continues to Grow
accessnewswire.com
LEXX
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
accessnewswire.com
LEXX
LLY
NVO
PFE
Lexaria Announces New R&D Plans for 2026
accessnewswire.com
LEXX
Lexaria Announces Positive Final Results From Human Pilot Study #5
accessnewswire.com
LEXX
Lexaria Awarded Six Additional Patents
accessnewswire.com
LEXX
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
globenewswire.com
LEXX
WST
NAGE
PM
Lexaria Releases Annual Letter from the CEO
accessnewswire.com
LEXX
LEXXW
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4
accessnewswire.com
LEXX
LEXXW